Filing Flows › Lantheus Holdings (LNTH) › Recalls, complaints & regulation
Lantheus Holdings (LNTH): clinical trials
Lantheus Holdings (LNTH) beyond its filings: 6 active clinical trials.
Lantheus Holdings' latest quarter
Lantheus Holdings, Q3 2026: revenue $390M (+2% year over year), operating margin 8.3%, net earnings $22.4M, operating cash flow $102M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Lantheus Holdings have?
6 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.